Navigation Links
Erectile Dysfunction Drug Viagra Launched In India By Pfizer

The most popular drug Viagra has been launched by the pharmaceutical company Pfizer in 30 different cities across India where more than 90 million men are believed to suffer from erectile dysfunction.// The drug company is expected to gain access to approximately 10 to 15 % of the market within the next two years according to K.G. Ananthakrishnan, senior director of drug company in charge of the Indian wing.

Several factors regarding the Indian Pharmaceutical market have been held responsible for Pfizer’s move to market the drug in the country. Although it was not possible to patent a drug in India, from 1970 until the beginning of this year, it was possible to patent the technique of drug production.

This meant that generic forms of the drug could be launched in India while it was against law in several other countries. This led to growth of reverse engineering of the brands that were legally protected elsewhere. Infact, a generic version of Viagra (Sildenafil Citrate) was available in India much before the launch of the launch of the pill in the U.S. drug market before 7 years.

An amendment in the patent law implemented later this year has led to a change in the scenario with the law falling in line with the one prevalent across other parts of the world. This also complies with the World Trade Organization’s TRIPS Agreement according to which a product can be protected against selling of copycat versions by other manufacturers for a period of 20 years.

In moving towards the new set of laws, India agreed that its generics drug companies would pull drugs that are copycat versions of drugs approved elsewhere after 1995. First approved by the FDA in 1998, Viagra brought Pfizer $1.68 billion in revenue in 2004.

A 50-gram dosage of the drug is to be priced at Rs. 463 and a 100 mg tablet at Rs. 594. This higher pricing would limit the affordability of all members of the society. This move only indicates the supreme confidence of Pfizer regarding the removal of other generic versions of Viagra from the Indian market.

This is yet another reason for the anticipated rise in sales of the erectile dysfunction drug. It is hoped that Indian customers would be willing to pay an optimal price for the genuine product.


'"/>




Related medicine news :

1. Erectile dysfunction (ED) signals vascular disease
2. An Exploration into Erectile Dysfunction in Diabetics
3. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
4. Cardiovascular Disease More Common Among Erectile Dysfunction Patients
5. Erectile Dysfunction Connected To Heart Disease
6. Statins For Erectile Dysfunction- An Alternative To Viagra?
7. Erectile Dysfunction Can Be Rectified By Healthy Way Of Life
8. Host of Benefits from Erectile Dysfunction Drugs
9. Erectile Dysfunction Linked with Smoking and Obesity – Study Report
10. South Africans Turn to Natural Remedies for Treating Erectile Dysfunction
11. HIV and Erectile Medications - No Link Found
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... ... 2017 , ... ERT, a global data and technology company ... a leading clinical development service provider, has selected ERT’s Trial Oversight suite as ... part to an array of circumstances including the use of multiple data capture ...
(Date:2/23/2017)... San Ramon, CA (PRWEB) , ... February 23, 2017 , ... ... Kaplan, MD, FACP, FACMPE, FACPE, will keynote their upcoming conference – Empowerment, Value and ... served as the chairman and CEO of the Virginia Mason Health System in Seattle ...
(Date:2/23/2017)... Va. (PRWEB) , ... February 23, 2017 , ... ... or problems. He has also continued to spiritually evolve, which is the purpose of ... book “ Our Spiritual Truths ” (published by Balboa Press) attempts to guide readers ...
(Date:2/22/2017)... Los Angeles, CA (PRWEB) , ... February 22, 2017 , ... ... medical detox treatment to the thousands of individuals who have recently fallen victim to ... accredited hospital in Orange County, California, where they are free from the shame, ...
(Date:2/22/2017)... ... February 22, 2017 , ... VitreosHealth ... each Medicare Advantage member’s risk, identify any gaps-in-coding, as well as gaps-in-care ... transform the HCC Risk Adjustment process from a typical fragmented process to ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Corp. (NYSE: NVRO), a global medical device company that is ... today reported financial results for the three months and full ... & Highlights: Achieved revenue of $228.5 million ... reported, over the prior year U.S. revenue of ... prior year International revenue of $55.2 million ...
(Date:2/23/2017)... DUBLIN , Feb 23, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Oesophageal Cancer ... What are the key drugs marketed for Oesophageal ...
(Date:2/23/2017)... Regulus Therapeutics Inc . (Nasdaq: RGLS), ... innovative medicines targeting microRNAs, today announced it will release ... Thursday, March 2, 2017 after the market closes. ... on March 2, 2017 at 5:00 p.m. Eastern Time ... results and provide a general business update.  A live ...
Breaking Medicine Technology: